EU Product Liability Directive: Transposition Tracker and Guidance
The new EU Product Liability Directive (PLD) extends strict, no-fault liability to software, including security vulnerabilities and missing updates. It sets common EU rules, but each Member State writes them into its own law, and claims are decided by national courts. EU Member States must transpose the EU Product Liability Directive into national law by 9 December 2026. Use the Comply.Land Product Liability Directive transposition tracker to follow implementation across all 27 Member States. Our tracker follows that process for each country, and is updated at least every two weeks.
EU Product Liability Directive Transposition: Why National Laws Matter
The EU Product Liability Directive does not apply to companies directly. What matters in a liability claim is the national law that implements it, and that law is still being written in most Member States.
Member States must transpose Directive (EU) 2024/2853 by 9 December 2026. The Product Liability Directive (PLD) applies to products placed on the market or put into service after the threshold stated in Article 2, so products launched end of 2026 will fall under the national rules.
Under the Rome II Regulation, the law that applies to a product liability claim generally depends on a hierarchy of connecting factors, which can include the injured person’s habitual residence, where the product was acquired, where damage occurred and whether the product was marketed in the relevant country. A company selling into several Member States may create cross-border exposure under several national laws.
In cases where a given Member State misses the deadline or adopts its law late, operators have less time to adjust contracts, insurance and documentation. Monitor both EU-level rules and the official legislative position in each relevant Member State; do not assume that a missed deadline means the new rules automatically apply unchanged to private parties.
Indemnities between manufacturers, importers and Authorised Representatives, and product liability cover should be reviewed against the national position before products ship, not after a claim. Contractual indemnities and rights of recourse between economic operators may allocate commercial risk, but cannot automatically remove liability to an injured person under the PLD. Review arrangements with qualified counsel and insurers.
Product Liability Directive Implementation by Country: What Can Differ?
The PLD is largely a maximum harmonisation directive; Member States cannot add stricter or looser liability rules at their own will. However, differences may remain in a few areas that matter.
Normally a manufacturer is not liable if the state of scientific and technical knowledge at the time could not reveal the defect. Member States may keep or, in some cases, introduce national rules that remove this defence. Where they do, operators lose a key defence in that market. This is the main point of divergence rated by our tracker.
Non-material losses linked to death, personal injury or damage to property are compensated only insofar as national law allows it. The same defect can lead to different amounts of compensation in different countries.
How disclosure of evidence is ordered, how confidential information is protected, whether collective actions are available and how costs are allocated all follow national procedural rules.
The Directive sets the three-year and ten-year periods, but when those periods are suspended or interrupted is governed by national law.
Claimants can still rely on national contractual or fault-based liability, and on special liability systems that already existed, alongside the PLD. These vary by country.
Member States transpose at different speeds and in their own legal language, which can create gaps or differences of interpretation during the transition.
PLD Transposition Tracker
Our Tracker follows the transposition status of all 27 Member States, and rates the liability exposure of an EU authorised representative in each country. It is maintained by Daniel Thompson-Yvetot, Founder and CEO of Comply.Land, using EUR-Lex national transposition measures as the source of record, alongside published legislative drafts and leading law-firm surveys.
Select a status to filter the table, and open a row to see how that country diverges from the Directive.
AustriaIn planningPendingPreparatory work begun by federal ministries (per Faegre Drinker, Jun 2026); no draft published
- National instrument
- Product Liability Act (PHG) amendment expected
- Transposition target
- 9 Dec 2026 (target)
- Development-risk defence
- TBD
- SME software-component recourse limit (Art. 12(2))
- TBD
- Non-material damage
- TBD
- Disclosure of evidence
- TBD
- Distributors and online platforms
- TBD
- Rome II and applicable law
- Directive baseline expected (TBD pending transposition)
- Authorised Representative exposure
- Directive baseline expected pending draft
- Notified to the Commission
- Pending
- Sources
- Faegre Drinker / Wolf Theiss
- Last change
- No change recorded since the tracker launched on this page (reviewed 16 Oct 2026)
BelgiumDraft (report)BaselinePreliminary draft bill approved by Council of Ministers 18 Jul 2026; before Council of State; not yet in Parliament (Conventus Law / CMS, 20 Aug 2026)
- National instrument
- Preliminary draft bill (avant-projet)
- Transposition target
- 9 Dec 2026 (target)
- Development-risk defence
- Retained (govt empowered to derogate later by decree)
- SME software-component recourse limit (Art. 12(2))
- Not detailed
- Non-material damage
- Not detailed
- Disclosure of evidence
- Expansive: evidence must be presented in easily accessible and understandable manner; courts may order production of newly created documents
- Distributors and online platforms
- Baseline
- Rome II and applicable law
- DRD available for now (removal power reserved to govt); expansive disclosure (new docs may be ordered); presumptions aligned with Civil Code Book 8
- Authorised Representative exposure
- AR liable per Art. 8; DRD retained but subject to later removal by decree; recourse contractual
- Notified to the Commission
- Pending
- Sources
- Conventus Law / CMS (20 Aug 2026)
- Last change
- No change recorded since the tracker launched on this page (reviewed 16 Oct 2026)
BulgariaIn planningPendingDraft finalisation targeted Aug 2026; Parliament approval targeted Nov 2026 (per Wolf Theiss, Apr 2026)
- National instrument
- New dedicated act expected
- Transposition target
- 9 Dec 2026 (target)
- Development-risk defence
- TBD
- SME software-component recourse limit (Art. 12(2))
- TBD
- Non-material damage
- TBD
- Disclosure of evidence
- TBD
- Distributors and online platforms
- TBD
- Rome II and applicable law
- Directive baseline expected (TBD pending transposition)
- Authorised Representative exposure
- Directive baseline expected pending draft
- Notified to the Commission
- Pending
- Sources
- Wolf Theiss (Apr 2026)
- Last change
- No change recorded since the tracker launched on this page (reviewed 16 Oct 2026)
CroatiaAdoptedBaselineAdopted by Sabor 19 Jun 2026; published NN 69/2026 (29 Jun 2026); PL provisions apply from 9 Dec 2026
- National instrument
- Amendments to Act on Obligations (NN 69/2026)
- Transposition target
- 9 Dec 2026
- Development-risk defence
- Retained (pierced for software updates, related services and substantial modification)
- SME software-component recourse limit (Art. 12(2))
- ENACTED (no recourse against micro and small software suppliers)
- Non-material damage
- Recoverable where flowing from personal injury, health damage or data destruction
- Disclosure of evidence
- Court-ordered disclosure (new Art. 1074.a); proportionality and trade-secret safeguards
- Distributors and online platforms
- Extended where liable operator not identified; online platforms in scope (DSA Art. 6(3) conditions)
- Rome II and applicable law
- DRD available; otherwise directive baseline
- Authorised Representative exposure
- AR liable per Art. 8; DRD retained; Art. 12(2) recourse shield enacted
- Notified to the Commission
- Likely listed
- Sources
- Narodne novine 69/2026 / Wolf Theiss / Covington
- Last change
- No change recorded since the tracker launched on this page (reviewed 16 Oct 2026)
CyprusBill publishedBaselineBill published (per Covington, rev. Jun 2026); note: Faegre Drinker (24 Jun 2026) still reports no significant progress
- National instrument
- Implementing bill
- Transposition target
- 9 Dec 2026 (target)
- Development-risk defence
- Retained
- SME software-component recourse limit (Art. 12(2))
- Not detailed
- Non-material damage
- Not detailed
- Disclosure of evidence
- Per directive (not detailed)
- Distributors and online platforms
- Baseline
- Rome II and applicable law
- DRD available; otherwise directive baseline
- Authorised Representative exposure
- AR liable per Art. 8; DRD retained; recourse contractual
- Notified to the Commission
- Pending
- Sources
- Covington (Jun 2026)
- Last change
- No change recorded since the tracker launched on this page (reviewed 16 Oct 2026)
CzechiaBill publishedBaselineBill published (per Covington Apr 2026); expands product and defendant definitions
- National instrument
- Civil Code amendments (draft in govt legislative database)
- Transposition target
- 9 Dec 2026 (target)
- Development-risk defence
- Retained
- SME software-component recourse limit (Art. 12(2))
- Not detailed
- Non-material damage
- Not detailed
- Disclosure of evidence
- Per directive (not detailed)
- Distributors and online platforms
- Baseline
- Rome II and applicable law
- DRD available; otherwise directive baseline
- Authorised Representative exposure
- AR liable per Art. 8; DRD retained; recourse contractual
- Notified to the Commission
- Pending
- Sources
- Covington / Wolf Theiss
- Last change
- No change recorded since the tracker launched on this page (reviewed 16 Oct 2026)
DenmarkBill publishedBaselineBill L 32 (Forslag til lov om produktansvar) fremsat in the Folketing in the Okt I sitting block from 7 Oct 2026 (Justitsministeren); consultation draft closed 6 Feb 2026
- National instrument
- New standalone Product Liability Act (replaces current)
- Transposition target
- 9 Dec 2026
- Development-risk defence
- Retained
- SME software-component recourse limit (Art. 12(2))
- Not detailed
- Non-material damage
- Not detailed
- Disclosure of evidence
- Expansive: courts may order production of newly created documents
- Distributors and online platforms
- ADDS fault-based distributor liability with reversed burden of proof
- Rome II and applicable law
- DRD available; expansive disclosure (new docs may be ordered); additional fault-based distributor route
- Authorised Representative exposure
- AR liable per Art. 8; DRD retained; note chain complexity from distributor regime
- Notified to the Commission
- Pending
- Sources
- Folketinget L 32 (Okt 2026) / Lovprogram 2026/27 (6 Oct 2026) / CMS Nordic Trio (Feb 2026)
- Last change
- No change recorded since the tracker launched on this page (reviewed 16 Oct 2026)
EstoniaNo public draftPendingNo published measure (Reed Smith survey 10 Sep 2026; re-checked 16 Oct 2026)
- National instrument
- TBC
- Transposition target
- 9 Dec 2026 (statutory)
- Development-risk defence
- TBD
- SME software-component recourse limit (Art. 12(2))
- TBD
- Non-material damage
- TBD
- Disclosure of evidence
- TBD
- Distributors and online platforms
- TBD
- Rome II and applicable law
- Directive baseline expected (TBD pending transposition)
- Authorised Representative exposure
- Directive baseline expected pending draft
- Notified to the Commission
- Pending
- Sources
- Reed Smith / Drug & Device Law (Sep 2026)
- Last change
- No change recorded since the tracker launched on this page (reviewed 16 Oct 2026)
FinlandBill publishedBaselineGovt bill HE 190/2026 vp submitted to Eduskunta 24 Sep 2026; INTRODUCES a development-risk defence, reversing the MoJ working-group position (report 2 Feb 2026); proposed entry into force 9 Dec 2026
- National instrument
- Amendments to Tuotevastuulaki (694/1990) and Consumer Protection Act ch. 12 (HE 190/2026 vp)
- Transposition target
- 9 Dec 2026 (target)
- Development-risk defence
- INTRODUCED by Govt bill (new exemption ground; reverses current Finnish no-DRD position)
- SME software-component recourse limit (Art. 12(2))
- General law
- Non-material damage
- Not detailed
- Disclosure of evidence
- Constrained: substantiated requests only, proportionality, no creation of new docs, right to be heard, no coercive enforcement
- Distributors and online platforms
- Baseline
- Rome II and applicable law
- DRD available per Govt bill (change from current Finnish law); constrained disclosure; eased access to presumptions ('excessive' dropped)
- Authorised Representative exposure
- AR liable per Art. 8; DRD introduced by HE 190/2026 (pending adoption; was NO-DRD under current law); recourse contractual
- Notified to the Commission
- Pending
- Sources
- HE 190/2026 vp / LKOS Law (25 Sep 2026) / CMS Nordic Trio (Feb 2026)
- Last change
- No change recorded since the tracker launched on this page (reviewed 16 Oct 2026)
FranceNo public draftPendingNo published measure (Reed Smith survey Sep 2026; re-checked 16 Oct 2026); dedicated transposition text planned per Govt answer to QE 11448 (12 May 2026); delays expected (Cleary Gottlieb, May 2026)
- National instrument
- TBC
- Transposition target
- 9 Dec 2026 (statutory)
- Development-risk defence
- TBD
- SME software-component recourse limit (Art. 12(2))
- TBD
- Non-material damage
- TBD
- Disclosure of evidence
- TBD
- Distributors and online platforms
- TBD
- Rome II and applicable law
- Directive baseline expected (TBD pending transposition)
- Authorised Representative exposure
- Directive baseline expected pending draft
- Notified to the Commission
- Pending
- Sources
- Cleary Gottlieb (May 2026) / Reed Smith (Sep 2026)
- Last change
- No change recorded since the tracker launched on this page (reviewed 16 Oct 2026)
GermanyBill publishedBaseline +Bundestag passed recast ProdHaftG 8 Oct 2026 (BT-Drs. 21/8429; govt bill BT-Drs. 21/4297); Bundesrat completed second passage 16 Oct 2026 (TOP 46, BR-Drs. 584/26, no mediation request); signature and BGBl promulgation pending
- National instrument
- Full recast ProdHaftG (standalone, 5 parts)
- Transposition target
- 9 Dec 2026 (promulgation pending)
- Development-risk defence
- Retained (pierced for update-failure defects, Art. 11(3))
- SME software-component recourse limit (Art. 12(2))
- NOT enacted (confirmed in Bundestag version; relies on contract law)
- Non-material damage
- Allowed under general civil-law principles
- Disclosure of evidence
- Via recast act s.19; committee extended disclosure to evidence held by third parties and added an in camera trade-secret procedure
- Distributors and online platforms
- Baseline
- Rome II and applicable law
- DRD available (carve-out for update-failure defects); non-material damage via general civil law; no Art. 12(2) recourse shield
- Authorised Representative exposure
- AR liability in ss.10-13; no statutory Art. 12(2) recourse shield for SME software components
- Notified to the Commission
- Pending
- Sources
- Bundesrat (16 Oct 2026, BR-Drs. 584/26) / Bundestag (BT-Drs. 21/8429) / Reed Smith
- Last change
- No change recorded since the tracker launched on this page (reviewed 16 Oct 2026)
GreeceNo public draftPendingNo published measure (Reed Smith survey 10 Sep 2026; re-checked 16 Oct 2026)
- National instrument
- TBC
- Transposition target
- 9 Dec 2026 (statutory)
- Development-risk defence
- TBD
- SME software-component recourse limit (Art. 12(2))
- TBD
- Non-material damage
- TBD
- Disclosure of evidence
- TBD
- Distributors and online platforms
- TBD
- Rome II and applicable law
- Directive baseline expected (TBD pending transposition)
- Authorised Representative exposure
- Directive baseline expected pending draft
- Notified to the Commission
- Pending
- Sources
- Reed Smith / Drug & Device Law (Sep 2026)
- Last change
- No change recorded since the tracker launched on this page (reviewed 16 Oct 2026)
HungaryAdoptedBaselineLaw adopted 16 Dec 2025 (njt.hu 2025-92); effective for products placed on market after 9 Dec 2026
- National instrument
- Transposing law (adopted 2025)
- Transposition target
- 9 Dec 2026
- Development-risk defence
- Retained (limited for pharmaceuticals)
- SME software-component recourse limit (Art. 12(2))
- Not detailed
- Non-material damage
- Covers damage to data and related non-pecuniary loss
- Disclosure of evidence
- Per directive (not detailed)
- Distributors and online platforms
- Extended where responsible operator not identified within one month; online platforms in scope in certain conditions
- Rome II and applicable law
- DRD available (narrowed for pharmaceuticals); otherwise directive baseline
- Authorised Representative exposure
- AR liable per Art. 8; DRD retained; recourse vs non-EU mfr is contractual
- Notified to the Commission
- Likely listed
- Sources
- Covington / Faegre Drinker / Wolf Theiss (Jun 2026)
- Last change
- No change recorded since the tracker launched on this page (reviewed 16 Oct 2026)
IrelandIn planningPendingLegislation being drafted as of May 2026 (per Faegre Drinker); deadline expected to be met; no text published
- National instrument
- TBC
- Transposition target
- 9 Dec 2026 (target)
- Development-risk defence
- TBD
- SME software-component recourse limit (Art. 12(2))
- TBD
- Non-material damage
- TBD
- Disclosure of evidence
- TBD
- Distributors and online platforms
- TBD
- Rome II and applicable law
- Directive baseline expected (TBD pending transposition)
- Authorised Representative exposure
- Directive baseline expected pending draft
- Notified to the Commission
- Pending
- Sources
- Lexology (2025)
- Last change
- No change recorded since the tracker launched on this page (reviewed 16 Oct 2026)
ItalyBill publishedBaselineSchema approved by CdM in preliminary examination 4 Aug 2026; Camera Atto del Governo 434 assigned 7 Aug 2026; XIV and V favourable opinions 16 Sep 2026; II Giustizia favourable with observations 23 Sep 2026; final CdM approval pending
- National instrument
- Legislative decree (schema di decreto legislativo) under delegation law
- Transposition target
- 9 Dec 2026 (target)
- Development-risk defence
- Retained (does not operate where defect stems from software, related services, updates or missed security updates)
- SME software-component recourse limit (Art. 12(2))
- Not detailed
- Non-material damage
- Includes destruction or corruption of data not used professionally (Art. 123 scheme)
- Disclosure of evidence
- Judicial disclosure mechanism with proportionality safeguards (Art. 119 scheme)
- Distributors and online platforms
- Subsidiary liability of distributors and online platforms where responsible operator not identified (Art. 116 scheme)
- Rome II and applicable law
- DRD available (pierced for software, updates and missed security updates); otherwise directive baseline
- Authorised Representative exposure
- AR liable per Art. 8; DRD retained with software carve-outs; recourse contractual
- Notified to the Commission
- Pending
- Sources
- Camera (AG 434) / Governo (CdM 4 Aug 2026) / dirittobancario (18 Aug 2026)
- Last change
- No change recorded since the tracker launched on this page (reviewed 16 Oct 2026)
LatviaNo public draftPendingNo published measure (Reed Smith survey 10 Sep 2026; re-checked 16 Oct 2026)
- National instrument
- TBC
- Transposition target
- 9 Dec 2026 (statutory)
- Development-risk defence
- TBD
- SME software-component recourse limit (Art. 12(2))
- TBD
- Non-material damage
- TBD
- Disclosure of evidence
- TBD
- Distributors and online platforms
- TBD
- Rome II and applicable law
- Directive baseline expected (TBD pending transposition)
- Authorised Representative exposure
- Directive baseline expected pending draft
- Notified to the Commission
- Pending
- Sources
- Reed Smith / Drug & Device Law (Sep 2026)
- Last change
- No change recorded since the tracker launched on this page (reviewed 16 Oct 2026)
LithuaniaAdoptedBaselineAdopted 25 Jun 2026 (per Reed Smith survey, 10 Sep 2026; Covington roll-up rev. 17 Aug 2026 concurs); TAR publication reference not yet verified against primary source
- National instrument
- Civil Code amendments
- Transposition target
- 9 Dec 2026
- Development-risk defence
- Not detailed
- SME software-component recourse limit (Art. 12(2))
- Not detailed
- Non-material damage
- Omits 'medically recognised' qualifier for psychological harm (potentially broader claims); data damage narrowed via Data Governance Act definition
- Disclosure of evidence
- Per directive (not detailed)
- Distributors and online platforms
- Baseline
- Rome II and applicable law
- Directive baseline expected; broader psychological-harm claims; narrower data-damage scope
- Authorised Representative exposure
- AR liable per Art. 8; DRD not confirmed in adopted text; recourse contractual
- Notified to the Commission
- Pending
- Sources
- Covington (rev. 17 Aug 2026) / Jones Day (Jun 2026)
- Last change
- No change recorded since the tracker launched on this page (reviewed 16 Oct 2026)
LuxembourgNo public draftPendingNo published measure (Reed Smith survey 10 Sep 2026; re-checked 16 Oct 2026)
- National instrument
- TBC
- Transposition target
- 9 Dec 2026 (statutory)
- Development-risk defence
- TBD
- SME software-component recourse limit (Art. 12(2))
- TBD
- Non-material damage
- TBD
- Disclosure of evidence
- TBD
- Distributors and online platforms
- TBD
- Rome II and applicable law
- Directive baseline expected (TBD pending transposition)
- Authorised Representative exposure
- Directive baseline expected pending draft
- Notified to the Commission
- Pending
- Sources
- Reed Smith / Drug & Device Law (Sep 2026)
- Last change
- No change recorded since the tracker launched on this page (reviewed 16 Oct 2026)
MaltaNo public draftPendingNo published measure (Reed Smith survey 10 Sep 2026; re-checked 16 Oct 2026)
- National instrument
- TBC
- Transposition target
- 9 Dec 2026 (statutory)
- Development-risk defence
- TBD
- SME software-component recourse limit (Art. 12(2))
- TBD
- Non-material damage
- TBD
- Disclosure of evidence
- TBD
- Distributors and online platforms
- TBD
- Rome II and applicable law
- Directive baseline expected (TBD pending transposition)
- Authorised Representative exposure
- Directive baseline expected pending draft
- Notified to the Commission
- Pending
- Sources
- Reed Smith / Drug & Device Law (Sep 2026)
- Last change
- No change recorded since the tracker launched on this page (reviewed 16 Oct 2026)
NetherlandsBill publishedBaselineBill 36906 submitted to Tweede Kamer 2 Mar 2026; nota n.a.v. verslag 3 Sep 2026; plenair debat scheduled 18 Jan 2027; convocatie wetgevingsoverleg 30 Sep 2026 (overleg 8 Feb 2027); vote pending
- National instrument
- Amendments to Civil Code (Books 6 & 7) + Transitional Act
- Transposition target
- After 9 Dec 2026 deadline likely (debate 18 Jan 2027)
- Development-risk defence
- Retained
- SME software-component recourse limit (Art. 12(2))
- Not detailed
- Non-material damage
- Draft does not expressly require medical recognition of psychological harm
- Disclosure of evidence
- Per directive (not detailed)
- Distributors and online platforms
- Baseline
- Rome II and applicable law
- DRD available; psychological harm recoverable without a medical-recognition requirement
- Authorised Representative exposure
- AR liable per Art. 8; DRD retained; recourse contractual
- Notified to the Commission
- Pending
- Sources
- Tweede Kamer (36906) / CMS / Covington
- Last change
- No change recorded since the tracker launched on this page (reviewed 16 Oct 2026)
PolandBill publishedBaselineDraft act published on legislacja.rcl.gov.pl 9 Sep 2026 (project 12414306, Ministry of Justice); assumptions entered the Council of Ministers register late Aug 2026
- National instrument
- Draft act amending the Civil Code and the Code of Civil Procedure
- Transposition target
- 9 Dec 2026 (target)
- Development-risk defence
- Not detailed
- SME software-component recourse limit (Art. 12(2))
- Not detailed
- Non-material damage
- Expanded catalogue of protected interests (detail pending analysis)
- Disclosure of evidence
- Right to demand disclosure of evidence; presumptions of defect and causation; eased evidentiary requirements
- Distributors and online platforms
- Broadened circle of liable operators where they contributed, for profit, to placing the defective product on the EU market
- Rome II and applicable law
- Directive baseline expected; DRD not yet confirmed in draft; eased evidence and presumptions for claimants
- Authorised Representative exposure
- AR liable per Art. 8; DRD not yet confirmed in draft; recourse contractual
- Notified to the Commission
- Pending
- Sources
- RCL project 12414306 (9 Sep 2026) / prawo.pl (8 Sep 2026) / Jones Day (Jun 2026)
- Last change
- No change recorded since the tracker launched on this page (reviewed 16 Oct 2026)
PortugalIn planningPendingPreparatory work ongoing (per Faegre Drinker, Jun 2026); no text published
- National instrument
- TBC
- Transposition target
- 9 Dec 2026 (target)
- Development-risk defence
- TBD
- SME software-component recourse limit (Art. 12(2))
- TBD
- Non-material damage
- TBD
- Disclosure of evidence
- TBD
- Distributors and online platforms
- TBD
- Rome II and applicable law
- Directive baseline expected (TBD pending transposition)
- Authorised Representative exposure
- Directive baseline expected pending draft
- Notified to the Commission
- Pending
- Sources
- Faegre Drinker (Jun 2026)
- Last change
- No change recorded since the tracker launched on this page (reviewed 16 Oct 2026)
RomaniaIn planningPendingAdded to Govt's 2026 transposition list; responsible body TBC
- National instrument
- TBC
- Transposition target
- 9 Dec 2026 (target)
- Development-risk defence
- TBD
- SME software-component recourse limit (Art. 12(2))
- TBD
- Non-material damage
- TBD
- Disclosure of evidence
- TBD
- Distributors and online platforms
- TBD
- Rome II and applicable law
- Directive baseline expected (TBD pending transposition)
- Authorised Representative exposure
- Directive baseline expected pending draft
- Notified to the Commission
- Pending
- Sources
- CMS / Wolf Theiss
- Last change
- No change recorded since the tracker launched on this page (reviewed 16 Oct 2026)
SlovakiaAdoptedBaseline +Approved by NRSR 17 Sep 2026; signed by President Pellegrini 29 Sep 2026; published as Act 242/2026 Z. z. (platnost 6 Oct 2026); effective 9 Dec 2026
- National instrument
- New standalone Act No. 242/2026 Z. z. on liability for damage caused by a defective product (replaces Act No. 294/1999)
- Transposition target
- 9 Dec 2026
- Development-risk defence
- Retained (s.7(1)(e) of Act 242/2026)
- SME software-component recourse limit (Art. 12(2))
- NOT enacted (recourse via general Civil Code, per published act)
- Non-material damage
- Not detailed
- Disclosure of evidence
- Court may order disclosure of evidence (published act)
- Distributors and online platforms
- Baseline
- Rome II and applicable law
- DRD available; no Art. 12(2) recourse shield for SME software components
- Authorised Representative exposure
- AR liable per Art. 8; no statutory Art. 12(2) recourse shield for SME software components
- Notified to the Commission
- Pending
- Sources
- Zbierka zakonov 242/2026 Z. z. / NRSR (17 Sep 2026) / CMS / Covington
- Last change
- No change recorded since the tracker launched on this page (reviewed 16 Oct 2026)
SloveniaBill publishedBaselineMoJ draft standalone act in inter-ministerial coordination, reported 15-17 Sep 2026; supersedes earlier Consumer Protection Act amendment path (Dec 2025)
- National instrument
- Standalone Product Liability Act (Zakon o odgovornosti za proizvode z napako)
- Transposition target
- 9 Dec 2026 (target)
- Development-risk defence
- Not detailed
- SME software-component recourse limit (Art. 12(2))
- Not detailed
- Non-material damage
- Not detailed
- Disclosure of evidence
- Expansive: courts may demand technical documentation, software updates and security assessments
- Distributors and online platforms
- Extended: any supply-chain operator making the product available where the manufacturer is unknown or outside the EU
- Rome II and applicable law
- Directive baseline expected; DRD not yet confirmed in draft; EUR 500 minimum threshold removed, no cap
- Authorised Representative exposure
- AR liable per Art. 8; DRD not yet confirmed in draft; recourse contractual
- Notified to the Commission
- Pending
- Sources
- zurnal24.si (17 Sep 2026) / racunovodja.com (15 Sep 2026) / Wolf Theiss (Apr 2026)
- Last change
- No change recorded since the tracker launched on this page (reviewed 16 Oct 2026)
SpainNo public draftPendingNo published measure (Reed Smith survey 10 Sep 2026; re-checked 16 Oct 2026)
- National instrument
- TBC
- Transposition target
- 9 Dec 2026 (statutory)
- Development-risk defence
- TBD
- SME software-component recourse limit (Art. 12(2))
- TBD
- Non-material damage
- TBD
- Disclosure of evidence
- TBD
- Distributors and online platforms
- TBD
- Rome II and applicable law
- Directive baseline expected (TBD pending transposition)
- Authorised Representative exposure
- Directive baseline expected pending draft
- Notified to the Commission
- Pending
- Sources
- Reed Smith / Drug & Device Law (Sep 2026)
- Last change
- No change recorded since the tracker launched on this page (reviewed 16 Oct 2026)
SwedenBill publishedBaselineProposition 2026/27:12 'En ny produktansvarslag' submitted to the Riksdag (published 15 Oct 2026); lagradsremiss decided 13 Aug 2026; proposed entry into force 1 Jan 2027
- National instrument
- New Product Liability Act
- Transposition target
- 1 Jan 2027 (proposed; after the 9 Dec 2026 deadline)
- Development-risk defence
- Retained
- SME software-component recourse limit (Art. 12(2))
- Not detailed
- Non-material damage
- Not detailed
- Disclosure of evidence
- Relies on existing procedural law; 'excessive' threshold dropped for presumptions; presumptions read as de facto reversed burden of proof
- Distributors and online platforms
- Baseline
- Rome II and applicable law
- DRD available; presumptions eased ('excessive' dropped); liability broadened beyond PLD minimum in places
- Authorised Representative exposure
- AR liable per Art. 8; DRD retained; recourse contractual
- Notified to the Commission
- Pending
- Sources
- Regeringen.se Prop. 2026/27:12 (15 Oct 2026) / SOU 2025:103 / CMS
- Last change
- No change recorded since the tracker launched on this page (reviewed 16 Oct 2026)
No Member States match this status.
AR exposure rating
How exposed an EU Authorised Representative is in each country, compared with the Directive baseline.
- High
- No development-risk defence in the national law. The Authorised Representative inherits strict, no-fault liability for the non-EU manufacturer with no state-of-the-art escape.
- Baseline +
- Directive-baseline Authorised Representative liability, but the Art. 12(2) SME software-component recourse limitation is not enacted.
- Baseline
- Authorised Representative liable under Art. 8, jointly and severally with the non-EU manufacturer. Recourse against the manufacturer is contractual only.
- Pending
- No published draft to assess. Directive baseline expected unless the state drops the development-risk defence.
Jurisdiction follows Brussels I Recast (claimant elects forum). Governing law follows Rome II Art. 5, uniform across fora. TBD means no published draft to assess.
How often we update the Tracker
We review every Member State at least every two weeks until the transposition deadline of 9 December 2026, and at least once a month after that. We also update a country as soon as it publishes a draft, adopts its law or notifies its transposition measure. Each country shows the date of its last change, and the page shows the date of the last full review.
This Tracker is provided for information only and does not constitute legal advice. Transposition measures change frequently. You should always verify the current position with the official sources listed and seek legal advice for your specific situation.
Who Is Liable Under the New EU Product Liability Directive?
The revised Product Liability Directive expands and clarifies the categories of economic operators that may be held liable for damage caused by defective products. Article 8 establishes a framework covering manufacturers and, in specified circumstances, other operators involved in supplying products to the European Union.
Manufacturers and software developers
Manufacturers remain the primary economic operators responsible under the PLD. The framework can also apply to software developers, manufacturers of connected devices and businesses supplying products under their own name or trademark. Manufacturers should consider how product design, cybersecurity, software updates, component traceability and technical documentation may affect potential liability.
Importers
Where a manufacturer is established outside the EU, an importer may be held liable for damage caused by a defective product under the conditions established by Article 8. Importers should understand their position within the supply chain and review access to technical information, contractual indemnities and product liability insurance.
EU Authorised Representatives
An EU Authorised Representative may face liability under the new Product Liability Directive where the manufacturer is established outside the European Union and the conditions of Article 8 are satisfied. An Authorised Representative performs specified regulatory tasks on behalf of a manufacturer under a written mandate. However, the mandate does not automatically exclude liability arising under the PLD. This distinction is particularly important for non-EU manufacturers considering how to structure their EU market presence. Manufacturers and Authorised Representatives should consider the implications for insurance, contractual recourse, product documentation and the allocation of responsibilities.
Fulfilment service providers and distributors
In certain circumstances, fulfilment service providers and distributors may also be held liable. The applicable provisions depend on their role in the supply chain and whether other responsible economic operators can be identified.
How Does the EU Product Liability Directive Affect Software and Connected Products?
The new Product Liability Directive expressly recognises software as a product, making the framework particularly relevant to developers of software, AI systems, connected devices and products with digital elements. Product defectiveness may arise not only from physical design or manufacturing issues but also from software behaviour, cybersecurity weaknesses and failures relating to necessary updates.
Cybersecurity vulnerabilities and product liability
Under the revised PLD, cybersecurity characteristics may be considered when determining whether a product provides the safety that a person is entitled to expect. A cybersecurity vulnerability does not automatically make a product defective or establish liability. The assessment depends on the circumstances, including the expected level of safety, qualifying damage and causation.
Missing software and security updates
A failure to provide necessary software or security updates may contribute to product defectiveness where the relevant software remains within the manufacturer’s control. Businesses should therefore consider how they document vulnerability handling, update decisions and responsibilities for maintaining product safety.
Artificial intelligence and software components
AI systems and software components can fall within the PLD framework. Where products depend on third-party software or connected services, contractual responsibilities, component traceability and access to relevant technical evidence can become particularly important.
Technical documentation and evidence
The Directive introduces mechanisms for disclosure of relevant evidence and presumptions that may apply in technically complex cases. Manufacturers and other economic operators should consider whether their documentation provides a reliable record of product safety decisions, cybersecurity measures, software changes and supplier responsibilities.
How Comply.Land Supports EU Product Regulatory Compliance
The Tracker tells you where the rules are heading. We help you prepare for them, by building the CRA compliance and evidence that PLD claims will test.
CRA Consultancy
If you sell into markets with higher exposure, the priority is reducing the risk of a defect and documenting what you did. We provide product-specific support on classification, gap assessment, vulnerability management and technical documentation, including how CRA obligations interact with the PLD.
CRA Workshops
Liability questions sit between engineering, legal and leadership teams. Our tailored workshops bring these teams together, with the CRA-PLD interplay and the national picture available as a topic.
EU Authorised Representative
For manufacturers outside the EU, an authorised representative that understands both the CRA obligations and the PLD liability that come with the mandate, market by market.
Learn more about EU Authorised Representative
Why Comply.Land?
European standards expertise. Comply.Land was established by professionals involved in European standards development, including ETSI Rapporteurs.
EU-based operations. Based in Malta, Comply.Land operates from an English-speaking European Union Member State.
Integrated regulatory support. Our focus on EU product regulation, cybersecurity requirements and economic-operator arrangements enables organisations to address connected compliance challenges.
How the PLD Connects to the Cyber Resilience Act
The CRA sets the cybersecurity requirements for products with digital elements. The PLD decides who pays when a product causes damage. The two are designed to work together.
Failure to meet mandatory product safety requirements is one of the circumstances in which a court shall presume a product is defective. CRA requirements are likely to be relevant here once they apply.
The CRA requires manufacturers to handle vulnerabilities and provide security updates throughout the support period. Under the PLD, a manufacturer cannot escape liability by arguing that a defect arose after the product was placed on the market where the defect results from a lack of software updates or upgrades necessary to maintain safety and the update was within the manufacturer’s control (Article 11(2)). The PLD itself does not create an obligation to provide updates; that obligation comes from the CRA.
The technical documentation, risk assessment and vulnerability-handling records required by the CRA are also the evidence a manufacturer will need if a liability claim arises.
The PLD applies to products placed on the market after 9 December 2026, a year before the CRA’s main obligations apply on 11 December 2027.
Frequently asked questions about the EU Product Liability Directive (PLD)
What is the new EU Product Liability Directive?
Directive (EU) 2024/2853 establishes harmonised rules for liability arising from defective products. It modernises the previous EU framework by expressly addressing software, connected products and digital technologies.
When does the new PLD apply?
Member States must transpose it by 9 December 2026. Under the corrected wording of Article 2(1), it applies to products placed on the market or put into service after 9 December 2026. Products placed on the market earlier remain under the previous regime.
If the PLD is an EU directive, why do national differences matter?
Claims are decided under national law. The Directive harmonises most of the rules, but Member States keep choices on the development-risk defence, and national law governs points such as non-material damage, court procedure and limitation periods.
How often is the Tracker updated?
At least every two weeks until 9 December 2026, and at least monthly after that. Immediate updates are released when a Member State publishes a draft or adopts its law. Each country shows the date of its last change.
Does the PLD apply to software?
Yes. Software is explicitly a product under the new Directive, including software embedded in hardware and standalone applications. Free and open-source software developed or supplied outside a commercial activity is excluded.
Can a security vulnerability make a product defective?
Yes, it can. Courts assess defectiveness against the safety a person is entitled to expect, taking into account relevant product safety requirements, including safety-relevant cybersecurity requirements.
How long does liability last?
Claims must generally be brought within three years of the injured person becoming aware of the damage, the defect and the liable operator. Liability usually expires 10 years after the product was placed on the market, extended to 25 years for latent personal injury. National law governs when the limitation period is suspended or interrupted.
Is the Tracker legal advice?
No. The Tracker is provided for information only. Always check the current position with the official sources and seek legal advice for your specific situation.
Does the PLD apply to non-EU manufacturers?
Yes. Products supplied to the EU market may fall within the PLD framework even where the manufacturer is established outside the European Union. Under specified conditions, EU-based importers, Authorised Representatives and other economic operators may also face liability.
Can an EU Authorised Representative be held liable under the PLD?
Yes. Article 8 establishes circumstances in which an Authorised Representative may be liable for damage caused by a defective product where the manufacturer is established outside the EU. The existence of a written regulatory mandate does not automatically exclude this statutory liability. Where it is liable, it is liable jointly and severally with the manufacturer. Our Tracker shows how national transposition affects this exposure.
Does compliance with the Cyber Resilience Act prevent PLD liability?
No. The CRA and PLD address different legal requirements. Compliance with cybersecurity obligations may be relevant when assessing product safety, but it does not guarantee that a product cannot be found defective under the PLD. However, meeting CRA requirements, keeping products updated and maintaining complete technical documentation reduce the risk of a defect and give a manufacturer the evidence it needs to respond to a claim.
Can manufacturers exclude PLD liability through contracts?
The Directive does not permit liability towards an injured person to be excluded or limited by contractual provisions. Commercial agreements between economic operators may nevertheless address indemnities and recourse, subject to applicable law.
How can I check Product Liability Directive implementation in a particular EU country?
The Comply.Land PLD Transposition Tracker provides information on national implementation status, legislative milestones and available official sources across the 27 EU Member States.
Stay Informed About EU Product Liability Directive Developments
The new EU Product Liability Directive introduces significant changes for manufacturers, software developers, importers and other economic operators supplying products across Europe.
Monitoring national implementation can help organisations understand the evolving liability framework and identify developments relevant to their products and markets.
Use the Comply.Land PLD Transposition Tracker to follow legislative progress across the European Union.